Form 4 for QDEL QuidelOrtho Corp
Accepted 2023-08-28 00:00:00 ET · period of report 2023-08-24 · accession 0001209191-23-047501 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-28 | 2023-08-24 | QDEL | BRYANT DOUGLAS C | Pres, CEO, Dir | A - Grant | $0.00 | +1,461 | 536.3K | +0.3% | $0 |
| D | 2023-08-28 | 2023-08-24 | QDEL | BRYANT DOUGLAS C | Pres, CEO, Dir | F - Tax | $78.33 | -725 | 535.6K | -0.1% | -$56.8K |
| D | 2023-08-28 | 2023-08-24 | QDEL | BRYANT DOUGLAS C | Pres, CEO, Dir | M - OptEx | $0.00 | -1,461 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-24 | A | A | 1,461 | $0.00 | 536,295 | D | — | — | (F1) Reflects release of restricted stock units that were previously reported on a Form 4. (F2) The amount of shares beneficially owned following this transaction includes an additional 291 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-08-24 | F | D | 725 | $78.33 | 535,570 | D | — | — | (F3) Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2023-08-24 | M | D | 1,461 | $0.00 | 0 | D | — · — to — | 1,461 Common Stock | (F4) Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. (F5) 1,461 shares vested on August 24, 2023. |